Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Teligent Inc. TLGTQ

Healthcare Drug Manufacturers - Specialty & Generic
Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like... see more

Recent & Breaking News (EXPM:TLGTQ)

Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018

GlobeNewswire November 2, 2018

Teligent, Inc. Announces FDA Approval of Desoximetasone Ointment USP 0.05%

GlobeNewswire October 24, 2018

Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05%

GlobeNewswire October 17, 2018

Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05%

GlobeNewswire October 2, 2018

Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage

GlobeNewswire August 16, 2018

Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage

Canada NewsWire August 14, 2018

Teligent, Inc. Announces Second Quarter 2018 Results

GlobeNewswire August 8, 2018

Teligent, Inc. to Hold Conference Call for Second Quarter 2018 Results

GlobeNewswire August 3, 2018

Teligent, Inc. Announces FDA Approval of Hydrocortisone Lotion USP, 2.5%

GlobeNewswire July 30, 2018

Teligent, Inc. Announces FDA Approval of Hydrocortisone Cream USP, 2.5%

GlobeNewswire July 24, 2018

Teligent, Inc. Announces FDA Approval of Lidocaine and Prilocaine Cream USP, 2.5%/2.5%

GlobeNewswire July 2, 2018

New Research: Key Drivers of Growth for Webster Financial, Chimerix, Commerce Bancshares, Teligent, Pinnacle Financial Partners, and Empire State Realty Trust — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire June 29, 2018

Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05%

GlobeNewswire June 20, 2018

Teligent, Inc. Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

GlobeNewswire June 13, 2018

Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility

GlobeNewswire June 5, 2018

Investor Expectations to Drive Momentum within Sun Communities, Anheuser-Busch InBev SA/NV, New Media Investment Group, Teligent, AptarGroup, and Pinnacle Financial Partners — Discovering Underlying Factors of Influence

GlobeNewswire May 17, 2018

Teligent, Inc. Announces First Quarter 2018 Results

GlobeNewswire May 8, 2018

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday, May 8, 2018

GlobeNewswire May 7, 2018

Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results

GlobeNewswire May 7, 2018

Teligent, Inc. to Host Earnings Call

Accesswire May 7, 2018